Purchases and Sales Made in Q1 2020 in Unity Biotechnology, Inc. (UBX)
This table provides information about the institutional ownership of Unity Biotechnology, Inc. (UBX) during Q1 2020. The information is specifically focused on institutions that hold shares of Unity Biotechnology, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Apr 21, 2020
Q1 2020
|
Raymond James & Associates
St Petersburg, FL |
SELL
|
- |
-52.7KClosed |
$264K - $401K
|
0
$0
|
|
May 15, 2020
Q1 2020
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-61.7K- 85.58% |
$308K - $469K
|
10.4K
$1.04K
|
|
May 15, 2020
Q1 2020
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-171K- 46.75% |
$857K - $1.3M
|
195K
$19.5K
|
|
May 14, 2020
Q1 2020
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-369K- 92.3% |
$1.84M - $2.8M
|
30.8K
$3.08K
|